Fortress Biotech
NASDAQ: FBIONew York, US · Delaware corporation
Fortress Biotech is a biopharmaceutical company that develops and commercializes pharmaceutical products, maintaining a pipeline of both revenue-generating commercial-stage products and development-stage drug candidates. It advances its products through partnerships within the pharmaceutical industry.
Biotech
Founders & leadership
LA
Lindsay A. RosenwaldExecutive
MS
Michael S. WeissExecutive
GA
George AvgerinosExecutive
LL
Lucy LuExecutive
Board
EK
Eric K. RowinskyBoard director
DK
Dov KleinBoard director
JH
Jimmie Harvey, Jr.Board director
MH
Malcolm HoenleinBoard director
JJ
J. Jay LobellBoard director
Reported raises · per SEC filings
Form D private placements$9.8M disclosed across 2 rounds · 2017–2018
▶$6.5MraisedMar 2018 · 2 investors · BiotechnologyRule 506(b)
▶$6.5MraisedMar 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- J. Jay LobellDirector
- George AvgerinosExecutive Officer
- Dov KleinDirector
- Malcolm HoenleinDirector
- Jimmie Harvey, Jr.Director
- Eric K. RowinskyDirector
- Michael WeissExecutive Officer, Director
- Robyn HunterExecutive Officer
- Lindsay A. RosenwaldExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $6.5M
- Sales commissions
- $521.4K
- Placement agents
- National Securities Corporation
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedApr 2017 · 2 investors · BiotechnologyRule 506(b)
▶$3.3MraisedApr 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eric K. RowinskyDirector
- Lindsay A. RosenwaldExecutive Officer, Director
- Michael S. WeissDirector
- Dov KleinDirector
- Jimmie Harvey, Jr.Director
- Malcolm HoenleinDirector
- J. Jay LobellDirector
- George AvgerinosExecutive Officer
- Lucy LuExecutive Officer
- Amount sold
- $3.3M
- Sales commissions
- $325.4K
- Placement agents
- National Securities Corporation
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Robinhood56 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking Alpha50 shared keywordsSeeking Alpha is a financial research platform that provides stock analysis, investment tools, and market coverage across asset classes to investors. The platform aggregates research from thousands of analysts and investors, offering ratings, articles, and investment ideas.
Companies competing with Fortress Biotech for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Fortress Biotech do?
- Fortress Biotech is a biopharmaceutical company that develops and commercializes pharmaceutical products, maintaining a pipeline of both revenue-generating commercial-stage products and development-stage drug candidates. It advances its products through partnerships within the pharmaceutical industry.
- How much funding has Fortress Biotech raised?
- Fortress Biotech has disclosed $9.8M raised across 2 rounds.
- Where is Fortress Biotech headquartered?
- Fortress Biotech is headquartered in New York, US.